| Product Code: ETC6164719 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Armenia Non-Small Cell Lung Cancer Diagnostics Market Overview |
3.1 Armenia Country Macro Economic Indicators |
3.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Armenia Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle |
3.4 Armenia Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces |
3.5 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.8 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Armenia Non-Small Cell Lung Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Armenia |
4.2.2 Technological advancements in diagnostic tools and techniques |
4.2.3 Growing awareness about early detection and treatment of lung cancer |
4.3 Market Restraints |
4.3.1 High costs associated with advanced diagnostic procedures |
4.3.2 Limited access to healthcare facilities in certain regions of Armenia |
4.3.3 Stringent regulatory requirements for approval of diagnostic tests |
5 Armenia Non-Small Cell Lung Cancer Diagnostics Market Trends |
6 Armenia Non-Small Cell Lung Cancer Diagnostics Market, By Types |
6.1 Armenia Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F |
6.1.4 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F |
6.1.5 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F |
6.1.6 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F |
6.2.3 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F |
6.3 Armenia Non-Small Cell Lung Cancer Diagnostics Market, By Test |
6.3.1 Overview and Analysis |
6.3.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.3.3 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F |
6.3.4 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.5 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F |
6.3.6 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F |
6.3.7 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.4 Armenia Non-Small Cell Lung Cancer Diagnostics Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.4 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F |
6.4.5 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Armenia Non-Small Cell Lung Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Armenia Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries |
7.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries |
8 Armenia Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators |
8.1 Average time taken for diagnosis from initial screening |
8.2 Rate of adoption of new diagnostic technologies |
8.3 Number of healthcare professionals trained in non-small cell lung cancer diagnostics |
9 Armenia Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment |
9.1 Armenia Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Armenia Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F |
9.4 Armenia Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Armenia Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape |
10.1 Armenia Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Armenia Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here